Linda M. Boxer - Publications

Affiliations: 
Stanford University, Palo Alto, CA 
Area:
Oncology, Molecular Biology

55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Xiang H, Noonan EJ, Wang J, Duan H, Ma LK, Michie S, Boxer LM. The Immunoglobulin Heavy Chain Gene 3’ Enhancers Induce Bcl2 Deregulation and Lymphomagenesis in Murine B Cells Leukemia. 25: 1484-1493. PMID 21606958 DOI: 10.1038/Leu.2011.115  0.424
2008 Duan H, Xiang H, Ma L, Boxer LM. Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells Oncogene. 27: 6720-6728. PMID 18695675 DOI: 10.1038/Onc.2008.286  0.392
2008 Saini HS, Chu AK, Boxer LM, Sato-Bigbee C. Signalling pathways linking proliferation and survival in oligodendrocyte progenitors Journal of Neurochemistry. 81: 46-48. DOI: 10.1046/J.1471-4159.81.S1.15_9.X  0.501
2007 Dhakshinamoorthy S, Sridharan SR, Li L, Ng PY, Boxer LM, Porter AG. Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability. Nucleic Acids Research. 35: 5439-51. PMID 17702766 DOI: 10.1093/Nar/Gkm594  0.522
2007 Gao J, Liu YG, Zhou Y, Boxer LM, Woolley FR, Zingaro RA. Artificial zinc(II) complexes regulate cell cycle and apoptosis-related genes in tumor cell lines. Chembiochem : a European Journal of Chemical Biology. 8: 332-40. PMID 17203500 DOI: 10.1002/Cbic.200600299  0.409
2007 Duan H, Heckman CA, Boxer LM. The immunoglobulin heavy-chain gene 3′ enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells Oncogene. 26: 2635-2641. PMID 17043638 DOI: 10.1038/Sj.Onc.1210061  0.572
2006 Xiang H, Wang J, Boxer LM. Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells. Molecular and Cellular Biology. 26: 8599-606. PMID 16982684 DOI: 10.1128/Mcb.01062-06  0.547
2006 Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM, Liang Q. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 800-2. PMID 16469847 DOI: 10.1096/Fj.05-5426Fje  0.506
2006 Heckman CA, Duan H, Garcia PB, Boxer LM. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression Oncogene. 25: 888-898. PMID 16186795 DOI: 10.1038/Sj.Onc.1209127  0.57
2005 Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Molecular Cancer Research : McR. 3: 585-96. PMID 16254192 DOI: 10.1158/1541-7786.Mcr-05-0111  0.495
2005 Duan H, Heckman CA, Boxer LM. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Molecular and Cellular Biology. 25: 1608-19. PMID 15713621 DOI: 10.1128/Mcb.25.5.1608-1619.2005  0.498
2005 Wang J, Boxer LM. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells. The Journal of Biological Chemistry. 280: 12766-73. PMID 15687498 DOI: 10.1074/Jbc.M412446200  0.504
2005 Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD. C/EBPα and C/EBPα Myeloid Oncoproteins Induce Bcl-2 Via Interaction of Their Basic Regions with NF-κB p50. Blood. 106: 2992-2992. DOI: 10.1182/Blood.V106.11.2992.2992  0.479
2005 Xiang H, Boxer LM. The Role of the cAMP-Response Element in the Bcl-2 Promoter in the Regulation of Endogenous Bcl-2 Expression and Apoptosis in Murine B Cells. Blood. 106: 2987-2987. DOI: 10.1182/Blood.V106.11.2987.2987  0.536
2005 Wang J, Boxer LM. The Role of p53 in C-myc Induced Lymphomagenesis Mediated by the IgH 3′ Enhancers. Blood. 106: 2610-2610. DOI: 10.1182/Blood.V106.11.2610.2610  0.507
2004 Saini HS, Gorse KM, Boxer LM, Sato-Bigbee C. Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells. Journal of Neurochemistry. 89: 951-61. PMID 15140194 DOI: 10.1111/J.1471-4159.2004.02365.X  0.536
2004 Fine BM, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J, Boxer LM. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood. 103: 1043-9. PMID 14525776 DOI: 10.1182/Blood-2003-05-1518  0.369
2004 Paz-Priel I, Cai DH, Wang D, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD. C/EBPα and C/EBPα Myeloid Oncoproteins Inhibit Apoptosis and Induce Bcl-2 Via DNA-Binding Dependent and Independent Mechanisms. Blood. 104: 2561-2561. DOI: 10.1182/Blood.V104.11.2561.2561  0.521
2004 Kanda K, Wong W, Boxer LM. Enhanced Apoptosis to Chemotherapeutic Agents Is Dependent on NFκB and Bcl2-Related Proteins but Is Independent of P53 and Bax in Burkitt’s Lymphoma Cells. Blood. 104: 1541-1541. DOI: 10.1182/Blood.V104.11.1541.1541  0.508
2004 Duan H, Heckman CA, Boxer LM. HDAC2 Plays a Role in Protecting t(14;18) Lymphoma Cells from Apoptosis by Up-Regulation of Bcl-2. Blood. 104: 1133-1133. DOI: 10.1182/Blood.V104.11.1133.1133  0.486
2003 Heckman CA, Cao T, Somsouk L, Duan H, Mehew JW, Zhang CY, Boxer LM. Critical Elements of the Immunoglobulin Heavy Chain Gene Enhancers for Deregulated Expression of Bcl-2 Cancer Research. 63: 6666-6673. PMID 14583460  0.45
2003 Heckman CA, Wheeler MA, Boxer LM. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells. Oncogene. 22: 7891-9. PMID 12970736 DOI: 10.1038/Sj.Onc.1206639  0.55
2003 Jambal P, Masterson S, Nesterova A, Bouchard R, Bergman B, Hutton JC, Boxer LM, Reusch JE, Pugazhenthi S. Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells. The Journal of Biological Chemistry. 278: 23055-65. PMID 12679364 DOI: 10.1074/Jbc.M212450200  0.502
2003 Pugazhenthi S, Nesterova A, Jambal P, Audesirk G, Kern M, Cabell L, Eves E, Rosner MR, Boxer LM, Reusch JE. Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. Journal of Neurochemistry. 84: 982-96. PMID 12603823 DOI: 10.1046/J.1471-4159.2003.01606.X  0.435
2002 Zhang CY, Wu YL, Boxer LM. Impaired proliferation and survival of activated B cells in transgenic mice that express a dominant-negative cAMP-response element-binding protein transcription factor in B cells. The Journal of Biological Chemistry. 277: 48359-65. PMID 12374787 DOI: 10.1074/Jbc.M209329200  0.502
2002 Heckman CA, Boxer LM. Allele-specific analysis of transcription factors binding to promoter regions Methods. 26: 19-26. PMID 12054901 DOI: 10.1016/S1046-2023(02)00004-X  0.45
2002 Heckman CA, Mehew JW, Boxer LM. NF-κb activates Bcl-2 expression in t(14;18) lymphoma cells Oncogene. 21: 3898-3908. PMID 12032828 DOI: 10.1038/Sj.Onc.1205483  0.536
2002 Hu HM, Arcinas M, Boxer LM. A Myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma. The Journal of Biological Chemistry. 277: 9819-24. PMID 11777933 DOI: 10.1074/Jbc.M111426200  0.525
2001 Li C, Ahlborn TE, Tokita K, Boxer LM, Noda A, Liu J. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells. Oncogene. 20: 8193-8202. PMID 11781835 DOI: 10.1038/Sj.Onc.1205046  0.356
2001 Boxer LM, Dang CV. Translocations involving c-myc and c-myc function Oncogene. 20: 5595-5610. PMID 11607812 DOI: 10.1038/Sj.Onc.1204595  0.453
2001 Freeland K, Boxer LM, Latchman DS. The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells Molecular Brain Research. 92: 98-106. PMID 11483246 DOI: 10.1016/S0169-328X(01)00158-9  0.482
2001 Sinha S, Jancarik J, Roginskaya V, Rothermund K, Boxer LM, Corey SJ. Suppression of apoptosis and granulocyte colony-stimulating factor-induced differentiation by an oncogenic form of Cbl. Experimental Hematology. 29: 746-55. PMID 11378270 DOI: 10.1016/S0301-472X(01)00647-6  0.418
2001 Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM. Negative regulation of bcl-2 expression by p53 in hematopoietic cells Oncogene. 20: 240-251. PMID 11313951 DOI: 10.1038/Sj.Onc.1204067  0.478
2000 Groot M, Boxer LM, Thiel G. Nerve growth factor- and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells. European Journal of Cell Biology. 79: 924-935. PMID 11152283 DOI: 10.1078/0171-9335-00126  0.478
2000 Kanda K, Hu H, Zhang L, Grandchamps J, Boxer LM. NF-κB Activity Is Required for the Deregulation of c-mycExpression by the Immunoglobulin Heavy Chain Enhancer Journal of Biological Chemistry. 275: 32338-32346. PMID 10931834 DOI: 10.1074/Jbc.M004148200  0.527
2000 Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JE. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. The Journal of Biological Chemistry. 275: 10761-6. PMID 10753867 DOI: 10.1074/Jbc.275.15.10761  0.459
2000 Heckman CA, Mehew JW, Ying GG, Introna M, Golay J, Boxer LM. A-Myb up-regulates bcl-2 through a Cdx binding site in t(14;18) lymphoma cells Journal of Biological Chemistry. 275: 6499-6508. PMID 10692454 DOI: 10.1074/Jbc.275.9.6499  0.574
1999 Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich KA, Boxer LM, Reusch JEB. Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein Journal of Biological Chemistry. 274: 27529-27535. PMID 10488088 DOI: 10.1074/Jbc.274.39.27529  0.491
1999 Chalaux E, López-Rovira T, Rosa JL, Pons G, Boxer LM, Bartrons R, Ventura F. A zinc-finger transcription factor induced by TGF-β promotes apoptotic cell death in epithelial Mv1Lu cells Febs Letters. 457: 478-482. PMID 10471833 DOI: 10.1016/S0014-5793(99)01051-0  0.393
1999 Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. The Journal of Biological Chemistry. 274: 15237-44. PMID 10329733 DOI: 10.1074/Jbc.274.21.15237  0.425
1999 Liu YZ, Boxer LM, Latchman DS. Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade. Nucleic Acids Research. 27: 2086-90. PMID 10219080 DOI: 10.1093/Nar/27.10.2086  0.413
1998 Smith MD, Dawson SJ, Boxer LM, Latchman DS. The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bbcl-2 gene expression. Nucleic Acids Research. 26: 4100-7. PMID 9722627 DOI: 10.1093/Nar/26.18.4100  0.422
1998 Smith MD, Ensor EA, Coffin RS, Boxer LM, Latchman DS. Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor. The Journal of Biological Chemistry. 273: 16715-22. PMID 9642226 DOI: 10.1074/Jbc.273.27.16715  0.472
1997 Heckman C, Mochon E, Arcinas M, Boxer LM. The WT1 Protein Is a Negative Regulator of the Normalbcl-2 Allele in t(14;18) Lymphomas Journal of Biological Chemistry. 272: 19609-19614. PMID 9235968 DOI: 10.1074/Jbc.272.31.19609  0.482
1997 Sullivan J, Feeley B, Guerra J, Boxer LM. Identification of the Major Positive Regulators of c-myb Expression in Hematopoietic Cells of Different Lineages Journal of Biological Chemistry. 272: 1943-1949. PMID 8999884 DOI: 10.1074/Jbc.272.3.1943  0.53
1996 Wilson BE, Mochon E, Boxer LM. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Molecular and Cellular Biology. 16: 5546-56. PMID 8816467 DOI: 10.1128/Mcb.16.10.5546  0.565
1996 Ji L, Mochon E, Arcinas M, Boxer LM. CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas. The Journal of Biological Chemistry. 271: 22687-91. PMID 8798441 DOI: 10.1074/Jbc.271.37.22687  0.495
1996 Phan S, Feeley B, Withers D, Boxer LM. Identification of an inducible regulator of c-myb expression during T-cell activation. Molecular and Cellular Biology. 16: 2387-2393. PMID 8628306 DOI: 10.1128/Mcb.16.5.2387  0.501
1995 Chen HM, Boxer LM. π1 Binding sites are negative regulators of bcl-2 expression in pre-B cells Molecular and Cellular Biology. 15: 3840-3847. PMID 7791791 DOI: 10.1128/Mcb.15.7.3840  0.523
1995 Ji L, Arcinas M, Boxer LM. The transcription factor, Nm23H2, binds to and activates the translocated c-myc allele in Burkitt's lymphoma. The Journal of Biological Chemistry. 270: 13392-8. PMID 7768941 DOI: 10.1074/Jbc.270.22.13392  0.492
1995 McCann S, Sullivan J, Guerra J, Arcinas M, Boxer LM. Repression of the c-myb Gene by WT1 Protein in T and B Cell Lines Journal of Biological Chemistry. 270: 23785-23789. PMID 7559553 DOI: 10.1074/Jbc.270.40.23785  0.546
1995 Guerra J, Withers D, Boxer L. Myb binding sites mediate negative regulation of c-myb expression in T-cell lines. Blood. 86: 1873-1880. DOI: 10.1182/Blood.V86.5.1873.Bloodjournal8651873  0.518
1994 Boxer LM. The Role of Oncogenes in Hematologic Malignancies Annual Review of Medicine. 45: 1-11. PMID 8198369 DOI: 10.1146/Annurev.Med.45.1.1  0.373
1989 Boxer LM, Prywes R, Roeder RG, Kedes L. The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor. Molecular and Cellular Biology. 9: 515-22. PMID 2710114 DOI: 10.1128/mcb.9.2.515-522.1989  0.422
1988 Gustafson TA, Miwa T, Boxer LM, Kedes L. Interaction of nuclear proteins with muscle-specific regulation sequences of the human cardiac α-actin promoter Molecular and Cellular Biology. 8: 4110-4119. PMID 3185542 DOI: 10.1128/Mcb.8.10.4110  0.464
Show low-probability matches.